KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate KORU ...

And welcome to the KORU Medical Systems’ Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode.

Piper Sandler has downgraded KORU Medical Systems (NASDAQ:KRMD) to neutral from overweight largely on valuation. The investment bank noted KORU's (NASDAQ:KRMD) valuation was "sitting near multi ...

According to one local report, via the Daily Mail, “The event … will take place aboard their $500 million megayacht, Koru, anchored in the Venetian Lagoon.” While Koru is said to sleep a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Meeting to be held in New York on April 9 hosted by Craig-Hallum. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Allowance for nonrealization of deferred tax assets (DTA). We have excluded the effect of recording a full valuation allowance on our deferred tax assets in the fourth quarter ended 2024 in the ...